| Literature DB >> 23991121 |
Anne L Solevåg1, Elisabeth H Eggen, Judith Schröder, Britt Nakstad.
Abstract
BACKGROUND: Several versions of the Pediatric Early Warning Score (PEWS) exist, but there is limited information available on the use of such systems in different contexts. In the present study, we aimed to examine the relationship between a modified version of The Brighton Paediatric Early Warning Score (PEWS) and patient characteristics in a Norwegian department of pediatric and adolescent medicine. In addition, we sought to establish guidelines for escalation in patient care based on the PEWS in our patient population.Entities:
Mesh:
Year: 2013 PMID: 23991121 PMCID: PMC3753259 DOI: 10.1371/journal.pone.0072534
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The Brighton Paediatric Early Warning Score (PEWS) modified for use in our department.
| 0 | 1 | 2 | 3 | |
|
| Normal respiratory rate and SpO2 | Respiratory rate ≥10 above normal parameters | Respiratory rate ≥20 above normal parameters | Respiratory rate ≥30 above normal parameters OR ≤5 below normal parameters |
|
|
|
|
| |
|
| No retractions | Retractions | Jugular retractions | Retractions or grunting |
|
|
|
|
| |
| FiO2>0.30 (CPAP/BiPAP) | FiO2>0.40 (CPAP/BiPAP) | FiO2>0.50 (CPAP/BiPAP) | ||
|
|
|
| ||
| ≥2 L/min O2 | ≥5 L/min O2 | ≥8 L/min O2 | ||
|
| Normal skin color | Pale | Grey or cyanotic | Grey or cyanotic AND mottled |
|
|
|
|
| |
| Capillary refill time of 1–2 s | Capillary refill time of 3 s | Tachycardia, 20–30 beats/min above normal rate | Tachycardia, >30 beats/min above normal rate | |
|
|
| |||
| Capillary refill time of 4 s | Bradycardia | |||
|
| ||||
| Capillary refill time of ≥5 s | ||||
|
| Alert | Voice | Pain | Unresponsive |
A maximum of 3 points can be assigned for each of 3 main components (respiration, circulation, and behavior/‘disability’). In addition, 2 additional points can be awarded if either continuous inhalation medications or continuous positive airway pressure (CPAP) treatments are being administered, and 2 additional points for the presence of persistent postoperative vomiting. Hence, the score ranges from 0 to 13, with zero representing a normal physiologic state.
Age-specific physiological heart rate and respiratory rate at rest.
| Age | Heart rate | Respiratory rate |
| (beats per minute) at rest | (breaths per minute) at rest | |
| 0–1 months | 100–180 | 40–60 |
| 1–12 months | 100–180 | 35–40 |
| 13 months to 3 years | 70–110 | 25–30 |
| 4–6 years | 70–110 | 21–23 |
| 7–12 years | 70–110 | 19–21 |
| 13–19 years | 55–90 | 16–18 |
Characteristics of the patients with a highest Pediatric Early Warning Score (PEWS) ≥3 compared to the patients with a highest PEWS of 0−2.
| Patient characteristics | PEWS ≥3 | PEWS 0–2 | p-value |
| Age (years)* | 2 (1.0–6.5) | 4 (1.5–12) | 0.001 |
| Median (IQR) | |||
| Sex (boy/girl) | 71/52 | 338/300 | 0.19 |
| Length of hospital stay (days)* | 3 (2–5) | 2 (1–3) | <0.001 |
| Median (IQR) | |||
| Oxygen supplementation* | 18/123 (14.6%) | 7/638 (1.1%) | <0.001 |
| Fluid resuscitation* | 9/123 (7.3%) | 8/638 (1.3%) | <0.001 |
| i.v. antibiotics* | 24/123 (19.5%) | 54/638 (8.5%) | <0.001 |
| i.v. rehydration | 20/123 (16.3%) | 75/638 (11.8%) | 0.11 |
| Rehydration via feeding tube | 4/123 (3.3%) | 20/638 (3.1%) | 0.56 |
| Readmission | 19/123 (15.4%) | 94/638 (14.7%) | 0.34 |
| Inpatient* | 107/123 (87.0%) | 388/638 (60.8%) | <0.001 |
p<0.05 is considered a significant difference (marked with *).
Distribution of diagnostic groups among the patients with a highest Pediatric Early Warning Score (PEWS) ≥3 compared to the patients with a highest PEWS of 0−2.
| PEWS ≥3 | PEWS 0–2 | p-value | Total | |
| Injury* | 3/123 (2.4%) | 89/638 (13.9%) | <0.001 | 92/761 (12.1%) |
| Congenital cardiovascular disease* | 5/123 (4.1%) | 5/638 (0.8%) | <0.001 | 10/761 (1.3%) |
| Acquired cardiovascular disease* | 4/123 (3.3%) | 11/683 (1.6%) | <0.001 | 15/761 (2.0%) |
| Neurological disease* | 8/123 (17.9%) | 100/638 (11.8%) | 0.007 | 108/761 (14.2%) |
| Renal disease including urinary tract infection* | 3/123 (2.4%) | 23/638 (3.6%) | <0.001 | 26/761 (3.4%) |
| Gastrointestinal disease* | 15/123 (12.2%) | 142/638 (22.3%) | 0.011 | 157/761 (20.6%) |
| Respiratory, upper airway disease* | 9/123 (7.3%) | 71/638 (11.1%) | <0.001 | 80/761 (10.5%) |
| Respiratory, lower airway disease* | 57/123 (46.4%) | 54/638 (8.5%) | <0.001 | 111/761 (14.6%) |
| ‘Other infection’* | 8/123 (6.5%) | 53/638 (8.3%) | <0.001 | 61/761 (8.0%) |
| Miscellaneous including dehydration and diabetes ketoacidosis | 11/123 (8.9%) | 90/638 (14.1%) | 0.15 | 82/761 (10.8%) |
p<0.05 is considered a significant difference (marked with *).